Axsome Therapeutics, Inc. (AXSM) › Total LiabilitiesAxsome Therapeutics, Inc. (AXSM) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2015: $2.63M2016: $16.64M2017: $18.84M2018: $14.44M2019: $41.83M2020: $72.34M2021: $72.15M2022: $221.92M2023: $397.26M2024: $511.48M2025: $601.51M$601.51M2015Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$601.51M+17.6%2024$511.48M+28.8%2023$397.26M+79.0%2022$221.92M+207.6%2021$72.15M-0.3%2020$72.34M+73.0%2019$41.83M+189.6%2018$14.44M-23.3%2017$18.84M+13.2%2016$16.64M+532.3%2015$2.63M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share